These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35994758)

  • 21. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
    Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
    Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
    Park Y; Hernandez-Diaz S; Bateman BT; Cohen JM; Desai RJ; Patorno E; Glynn RJ; Cohen LS; Mogun H; Huybrechts KF
    Am J Psychiatry; 2018 Jun; 175(6):564-574. PubMed ID: 29730938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression.
    Cantù F; Ciappolino V; Enrico P; Moltrasio C; Delvecchio G; Brambilla P
    J Affect Disord; 2021 Feb; 280(Pt A):45-53. PubMed ID: 33202337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
    Stauffer V; Ascher-Svanum H; Liu L; Ball T; Conley R
    BMC Psychiatry; 2009 Mar; 9():13. PubMed ID: 19335905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of antipsychotics in the management of fibromyalgia.
    Calandre EP; Rico-Villademoros F
    CNS Drugs; 2012 Feb; 26(2):135-53. PubMed ID: 22296316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Suo T; Komossa K; Ma H; Rummel-Kluge C; El-Sayeh HG; Leucht S; Xia J
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006569. PubMed ID: 24385408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-generation antipsychotics for anxiety disorders.
    Depping AM; Komossa K; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008120. PubMed ID: 21154392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
    Hershenberg R; Gros DF; Brawman-Mintzer O
    CNS Drugs; 2014 Jun; 28(6):519-33. PubMed ID: 24794100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S; Gutwinski S; Bschor T
    Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
    Chen J; Gao K; Kemp DE
    Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amisulpride versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Silveira da Mota Neto JI; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD006624. PubMed ID: 20091599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
    Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F
    Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.